Edesa Biotech (EDSA)
Edesa Biotech on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
204K
Short interest
settlement 2026-09-30
4.8
Days to cover
-1.9 days vs prior
56.9%
Short share of volume
2026-10-23
24
Fails to deliver
settlement 2026-09-30
Fri 11 Dec
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in EDSA is 203,556 shares, down 41,874 shares over the last month. Over the last 48 readings it ranged from 4,728 shares (15 January 2025) to 1,411,103 shares (27 February 2026). At the reported average volume of 42K shares a day that is 4.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/edsa" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 203,556 | -7.0% | 42,306 | 4.81 |
| 2026-09-15 | 218,773 | -10.9% | 32,819 | 6.67 |
| 2026-08-31 | 245,430 | +17.5% | 136,840 | 1.79 |
| 2026-08-14 | 208,955 | -3.4% | 35,741 | 5.85 |
| 2026-07-31 | 216,390 | -23.5% | 73,162 | 2.96 |
| 2026-07-15 | 282,929 | -0.1% | 52,762 | 5.36 |
| 2026-06-30 | 283,230 | -1.3% | 149,603 | 1.89 |
| 2026-06-15 | 287,082 | +20.3% | 294,726 | 1.00 |
| 2026-05-29 | 238,707 | +9.2% | 419,168 | 1.00 |
| 2026-05-15 | 218,598 | -57.4% | 363,030 | 1.00 |
| 2026-04-30 | 513,538 | +91.9% | 1,623,757 | 1.00 |
| 2026-04-15 | 267,664 | -32.5% | 266,842 | 1.00 |
| 2026-03-31 | 396,830 | -34.2% | 1,514,829 | 1.00 |
| 2026-03-13 | 603,458 | -57.2% | 8,431,585 | 1.00 |
| 2026-02-27 | 1,411,103 | +9253.7% | 13,657,948 | 1.00 |
| 2026-02-13 | 15,086 | -47.0% | 140,923 | 1.00 |
| 2026-01-30 | 28,454 | +103.8% | 85,292 | 1.00 |
| 2026-01-15 | 13,960 | -49.9% | 26,349 | 1.00 |
| 2025-12-31 | 27,859 | -20.0% | 57,428 | 1.00 |
| 2025-12-15 | 34,823 | -31.8% | 41,116 | 1.00 |
| 2025-11-28 | 51,065 | -10.6% | 20,367 | 2.51 |
| 2025-11-14 | 57,143 | -55.2% | 87,263 | 1.00 |
| 2025-10-31 | 127,522 | +1267.1% | 1,430,977 | 1.00 |
| 2025-10-15 | 9,328 | +33.6% | 94,782 | 1.00 |
| 2025-09-30 | 6,981 | +1.1% | 152,679 | 1.00 |
| 2025-09-15 | 6,902 | -17.9% | 8,530 | 1.00 |
| 2025-08-29 | 8,410 | +18.6% | 24,380 | 1.00 |
| 2025-08-15 | 7,089 | +10.7% | 17,764 | 1.00 |
| 2025-07-31 | 6,405 | -60.2% | 34,478 | 1.00 |
| 2025-07-15 | 16,099 | -36.0% | 33,542 | 1.00 |
| 2025-06-30 | 25,141 | -13.1% | 13,789 | 1.82 |
| 2025-06-13 | 28,919 | +112.8% | 18,598 | 1.55 |
| 2025-05-30 | 13,592 | -39.1% | 46,929 | 1.00 |
| 2025-05-15 | 22,317 | -45.6% | 18,719 | 1.19 |
| 2025-04-30 | 41,041 | -24.7% | 8,966 | 4.58 |
| 2025-04-15 | 54,514 | -25.4% | 8,486 | 6.42 |
| 2025-03-31 | 73,064 | -25.0% | 22,122 | 3.30 |
| 2025-03-14 | 97,391 | -9.2% | 50,837 | 1.92 |
| 2025-02-28 | 107,300 | -87.4% | 101,583 | 1.06 |
| 2025-02-14 | 852,078 | +4933.5% | 11,662,193 | 1.00 |
| 2025-01-31 | 16,928 | +258.0% | 40,786 | 1.00 |
| 2025-01-15 | 4,728 | -13.7% | 13,161 | 1.00 |
| 2024-12-31 | 5,476 | -74.5% | 24,400 | 1.00 |
| 2024-12-13 | 21,463 | -39.5% | 42,147 | 1.00 |
| 2024-11-29 | 35,490 | -26.8% | 17,890 | 1.98 |
| 2024-11-15 | 48,461 | +192.8% | 80,174 | 1.00 |
| 2024-10-31 | 16,551 | -16.6% | 12,642 | 1.31 |
| 2024-10-15 | 19,836 | +58.3% | 19,117 | 1.04 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of EDSA volume is 56.9%, up 27.4 points over the last five sessions. Over the last 30 readings it ranged from 18.3% (25 September 2026) to 70.1% (22 October 2026). The latest reading is 16.7 points above the 30-session average of 40.3%, on 11K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 6K | 11K | 56.9% | 0 |
| 2026-10-22 | 10K | 14K | 70.1% | 0 |
| 2026-10-21 | 7K | 11K | 58.8% | 0 |
| 2026-10-20 | 9K | 24K | 38.1% | 0 |
| 2026-10-19 | 6K | 19K | 34.0% | 0 |
| 2026-10-16 | 5K | 16K | 29.6% | 0 |
| 2026-10-15 | 10K | 27K | 37.2% | 0 |
| 2026-10-14 | 7K | 27K | 25.0% | 0 |
| 2026-10-13 | 15K | 23K | 65.3% | 2,482 |
| 2026-10-12 | 22K | 37K | 58.1% | 1,540 |
| 2026-10-09 | 3K | 15K | 20.2% | 0 |
| 2026-10-08 | 4K | 12K | 32.0% | 0 |
| 2026-10-07 | 7K | 10K | 69.1% | 0 |
| 2026-10-06 | 2K | 4K | 39.7% | 100 |
| 2026-10-05 | 18K | 33K | 56.1% | 0 |
| 2026-10-02 | 3K | 9K | 35.8% | 0 |
| 2026-10-01 | 2K | 8K | 22.2% | 0 |
| 2026-09-30 | 15K | 26K | 57.7% | 0 |
| 2026-09-29 | 4K | 13K | 29.8% | 0 |
| 2026-09-28 | 3K | 17K | 20.3% | 0 |
| 2026-09-25 | 976 | 5K | 18.3% | 0 |
| 2026-09-24 | 2K | 6K | 24.9% | 0 |
| 2026-09-23 | 3K | 9K | 29.0% | 0 |
| 2026-09-22 | 2K | 9K | 21.0% | 0 |
| 2026-09-21 | 4K | 12K | 37.8% | 0 |
| 2026-09-18 | 8K | 17K | 48.4% | 0 |
| 2026-09-17 | 2K | 10K | 25.7% | 0 |
| 2026-09-16 | 16K | 32K | 49.5% | 0 |
| 2026-09-15 | 6K | 11K | 53.5% | 0 |
| 2026-09-14 | 12K | 27K | 44.2% | 1,367 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in EDSA is 24 shares, down 611 shares over the last settlement date. Over the last 30 readings it ranged from 4 shares (10 September 2026) to 7,355 shares (16 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 24 | $3.56 | $85 |
| 2026-09-25 | 635 | $4.03 | $3K |
| 2026-09-16 | 278 | $4.12 | $1K |
| 2026-09-10 | 4 | $4.72 | $19 |
| 2026-09-09 | 2,484 | $4.73 | $12K |
| 2026-09-08 | 1,799 | $4.73 | $9K |
| 2026-09-03 | 156 | $4.76 | $743 |
| 2026-09-02 | 677 | $4.78 | $3K |
| 2026-08-31 | 335 | $4.62 | $2K |
| 2026-08-27 | 4,786 | $4.94 | $24K |
| 2026-08-25 | 8 | $4.40 | $35 |
| 2026-08-24 | 1,397 | $4.43 | $6K |
| 2026-08-21 | 3,084 | $4.76 | $15K |
| 2026-08-19 | 124 | $5.71 | $708 |
| 2026-08-14 | 345 | $5.43 | $2K |
| 2026-08-03 | 801 | $5.11 | $4K |
| 2026-07-13 | 926 | $7.01 | $6K |
| 2026-07-10 | 2,370 | $7.02 | $17K |
| 2026-07-09 | 38 | $7.31 | $278 |
| 2026-07-08 | 32 | $7.30 | $234 |
| 2026-07-02 | 263 | $7.75 | $2K |
| 2026-07-01 | 3,273 | $8.13 | $27K |
| 2026-06-30 | 229 | $7.67 | $2K |
| 2026-06-24 | 262 | $7.64 | $2K |
| 2026-06-23 | 262 | $6.81 | $2K |
| 2026-06-22 | 118 | $7.35 | $867 |
| 2026-06-18 | 2,876 | $6.88 | $20K |
| 2026-06-17 | 2,644 | $6.27 | $17K |
| 2026-06-16 | 7,355 | $5.94 | $44K |
| 2026-06-12 | 821 | $5.65 | $5K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for EDSA in the last 90 days. The most recent filings are listed below. Latest filing: Nijhawan Pardeep (Chief Executive Officer) on 2026-10-05.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Nijhawan Pardeep | Chief Executive Officer | Grant | 7K | $0.00 | $0 | 906K |
| 2026-09-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 899K |
| 2026-08-03 | Nijhawan Pardeep | Chief Executive Officer | Grant | 5K | $0.00 | $0 | 893K |
| 2026-07-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 888K |
| 2026-06-16 | Nijhawan Pardeep | Chief Executive Officer | Grant | 154K | $5.21 | $800K | 885K |
| 2026-06-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 2K | $0.00 | $0 | 731K |
| 2026-05-27 | Marshall Patrick | Director | Grant | 19K | $0.00 | $0 | 72K |
| 2026-05-27 | MacDonald Sean Arthur | Director | Grant | 19K | $0.00 | $0 | 41K |
| 2026-05-27 | Weiler Peter J. | Chief Financial Officer | Grant | 65K | $0.00 | $0 | 130K |
| 2026-05-27 | Sistilli Carlo | Director | Grant | 19K | $0.00 | $0 | 49K |
| 2026-05-27 | Olson Charles V | Director | Grant | 19K | $0.00 | $0 | 30K |
| 2026-05-27 | Nijhawan Pardeep | Chief Executive Officer | Grant | 97K | $0.00 | $0 | 729K |
| 2026-05-27 | Liu Da David | Director | Grant | 19K | $0.00 | $0 | 25K |
| 2026-05-27 | Chypyha Joan | Director | Grant | 19K | $0.00 | $0 | 30K |
| 2026-05-27 | Brooks Michael J | President | Grant | 65K | $0.00 | $0 | 291K |
| 2026-05-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 1K | $0.00 | $0 | 633K |
| 2026-04-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 631K |
| 2026-03-10 | Nijhawan Pardeep | Chief Executive Officer | Buy | 1K | $6.60 | $7K | 629K |
| 2026-03-05 | Nijhawan Pardeep | Chief Executive Officer | Buy | 10K | $3.90 | $39K | 403K |
| 2026-03-04 | Nijhawan Pardeep | Chief Executive Officer | Buy | 10K | $4.26 | $43K | 393K |
| 2026-03-03 | Nijhawan Pardeep | Chief Executive Officer | Buy | 10K | $3.63 | $36K | 383K |
| 2026-03-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 10K | $0.00 | $0 | 626K |
| 2026-03-02 | Nijhawan Pardeep | Chief Executive Officer | Buy | 1K | $2.28 | $2K | 373K |
| 2026-03-02 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $2.00 | $4K | 628K |
| 2026-02-27 | Nijhawan Pardeep | Chief Executive Officer | Buy | 30K | $2.22 | $67K | 372K |
| 2026-02-26 | Nijhawan Pardeep | Chief Executive Officer | Buy | 21K | $1.58 | $32K | 616K |
| 2026-02-26 | Brooks Michael J | President | Buy | 2K | $1.57 | $3K | 227K |
| 2026-02-19 | Nijhawan Pardeep | Chief Executive Officer | Grant | 82K | $0.00 | $0 | 595K |
| 2026-02-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 11K | $0.00 | $0 | 513K |
| 2026-01-05 | Nijhawan Pardeep | Chief Executive Officer | Grant | 10K | $0.00 | $0 | 502K |
| 2025-12-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 9K | $0.00 | $0 | 491K |
| 2025-11-03 | Nijhawan Pardeep | Chief Executive Officer | Grant | 7K | $0.00 | $0 | 483K |
| 2025-10-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 476K |
| 2025-09-11 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 470K |
| 2025-08-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 7K | $0.00 | $0 | 464K |
| 2025-07-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 7K | $0.00 | $0 | 457K |
| 2025-06-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 8K | $0.00 | $0 | 450K |
| 2025-05-29 | Liu Da David | Director | Grant | 6K | $0.00 | $0 | 6K |
| 2025-05-29 | Weiler Peter J. | Chief Financial Officer | Grant | 65K | $0.00 | $0 | 65K |
| 2025-05-29 | Brooks Michael J | President | Grant | 207K | $0.00 | $0 | 225K |
| 2025-05-29 | Chypyha Joan | Director | Grant | 11K | $0.00 | $0 | 11K |
| 2025-05-29 | MacDonald Sean Arthur | Director | Grant | 20K | $0.00 | $0 | 22K |
| 2025-05-29 | Nijhawan Pardeep | Chief Executive Officer | Grant | 263K | $0.00 | $0 | 442K |
| 2025-05-29 | Sistilli Carlo | Director | Grant | 20K | $0.00 | $0 | 30K |
| 2025-05-29 | Olson Charles V | Director | Grant | 11K | $0.00 | $0 | 11K |
| 2025-05-29 | Marshall Patrick | Director | Grant | 11K | $0.00 | $0 | 53K |
| 2025-05-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 179K |
| 2025-04-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 173K |
| 2025-03-03 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 167K |
| 2025-02-12 | Marshall Patrick | Director | Grant | 42K | $1.92 | $80K | 42K |
| 2025-02-12 | Sistilli Carlo | Director | Grant | 10K | $1.92 | $20K | 10K |
| 2025-02-03 | Nijhawan Pardeep | Chief Executive Officer | Grant | 8K | $0.00 | $0 | 160K |
| 2025-01-06 | Nijhawan Pardeep | Chief Executive Officer | Grant | 8K | $0.00 | $0 | 152K |
| 2024-12-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 6K | $0.00 | $0 | 144K |
| 2024-11-12 | Nijhawan Pardeep | Chief Executive Officer | Grant | 5K | $0.00 | $0 | 137K |
| 2024-10-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 133K |
| 2024-09-03 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 129K |
| 2024-08-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 126K |
| 2024-07-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 4K | $0.00 | $0 | 123K |
| 2024-06-03 | Nijhawan Pardeep | Chief Executive Officer | Grant | 5K | $0.00 | $0 | 119K |
| 2024-05-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 114K |
| 2024-04-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 111K |
| 2024-03-25 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5K | $4.00 | $20K | 342K |
| 2024-03-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 108K |
| 2024-02-01 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 105K |
| 2024-01-08 | Nijhawan Pardeep | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 102K |
| 2023-08-04 | Nijhawan Pardeep | Chief Executive Officer | Grant | 99K | price not stated in the filing | not stated | 694K |
| 2023-08-04 | Brooks Michael J | President | Grant | 93K | price not stated in the filing | not stated | 124K |
| 2023-08-04 | Lemieux Stephen | Chief Financial Officer | Grant | 17K | price not stated in the filing | not stated | 17K |
| 2023-01-10 | van der Velden Peter | TenPercentOwner | Sell | 139K | $2.63 | $367K | 1.6M |
| 2023-01-10 | van der Velden Peter | TenPercentOwner | Sell | 13K | $2.63 | $34K | 150K |
| 2023-01-09 | van der Velden Peter | TenPercentOwner | Sell | 133K | $2.66 | $353K | 1.8M |
| 2023-01-09 | van der Velden Peter | TenPercentOwner | Sell | 12K | $2.66 | $33K | 163K |
| 2022-11-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 228K | $1.13 | $257K | 228K |
| 2022-11-02 | Nijhawan Pardeep | Chief Executive Officer | Grant | 228K | $1.13 | $258K | 2.4M |
| 2022-11-02 | NIFFENEGGER KATHI | Chief Financial Officer | Grant | 9K | $1.13 | $10K | 11K |
| 2022-11-02 | Brooks Michael J | President | Grant | 4K | $1.13 | $5K | 30K |
| 2022-06-30 | Pardeep Nijhawan Medicine Professional Corp | Chief Executive Officer | Buy | 20K | $1.60 | $32K | 595K |
| 2022-06-29 | Brooks Michael J | President | Buy | 3K | $1.49 | $4K | 26K |
| 2022-06-16 | Brooks Michael J | President | Buy | 3K | $1.61 | $5K | 23K |
| 2022-05-27 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5K | $1.92 | $10K | 575K |
| 2022-05-25 | Brooks Michael J | President | Buy | 4K | $1.74 | $6K | 20K |
| 2022-05-24 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $1.80 | $4K | 570K |
| 2022-03-31 | Pardeep Nijhawan Medicine Professional Corp | Chief Executive Officer | Buy | 2K | $2.99 | $6K | 568K |
| 2022-03-30 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $3.05 | $6K | 566K |
| 2022-03-29 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $3.02 | $6K | 564K |
| 2022-03-18 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $3.85 | $8K | 562K |
| 2022-03-17 | Nijhawan Pardeep | Chief Executive Officer | Buy | 397 | $3.25 | $1K | 558K |
| 2022-03-17 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $3.26 | $5K | 560K |
| 2022-03-15 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $2.80 | $6K | 558K |
| 2022-03-14 | Brooks Michael J | President | Buy | 1K | $2.79 | $3K | 17K |
| 2022-03-11 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5K | $3.06 | $15K | 556K |
| 2022-03-11 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $3.18 | $6K | 551K |
| 2022-03-10 | Brooks Michael J | President | Buy | 1K | $3.22 | $3K | 15K |
| 2022-03-09 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2K | $3.05 | $5K | 549K |
| 2022-03-08 | Brooks Michael J | President | Buy | 1K | $2.90 | $4K | 14K |
| 2021-03-25 | Brooks Michael J | President | Buy | 4K | $5.19 | $18K | 13K |
| 2021-03-25 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3K | $5.25 | $16K | 545K |
| 2021-03-24 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5K | $5.16 | $26K | 542K |
| 2021-03-24 | Brooks Michael J | President | Buy | 5K | $5.08 | $23K | 10K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON23 holders report 5% or more of EDSA in their latest filing, 8 on Schedule 13D (active intent). The largest reported stake is Pardeep Nijhawan at 16.3% of the class (2,613,492 shares), filed 2026-08-25 for an event on 2026-08-21.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-26 | 13G | Stonepine Capital, L.P.partnership | 954K | 6.9% | 2026-08-20 |
| 2026-08-26 | 13G | Stonepine GP, LLCother entity | 954K | 6.9% | 2026-08-20 |
| 2026-08-26 | 13G | Stonepine Capital Management, LLCinvestment adviser, other entity | 954K | 6.9% | 2026-08-20 |
| 2026-08-26 | 13G | Jon M. Plexicoparent holding company, individual | 954K | 6.9% | 2026-08-20 |
| 2026-08-25 | 13D/Ano. 11 | Pardeep Nijhawanindividual | 2.6M | 16.3% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 11 | Pardeep Nijhawan Medicine Professional Corporationcorporation | 1.2M | 7.8% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 11 | 1968160 Ontario Inc.corporation | 53K | 0.4% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 11 | The Digestive Health Clinic Inc.corporation | 32K | 0.2% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 11 | The New Nijhawan Family Trust 2015other entity | 33K | 0.2% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Capital Management LLCother entity | 1.4M | 10.0% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | VENKATARAMAN BALAJIindividual | 1.4M | 10.0% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Morgan Adamindividual | 1.4M | 10.0% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Capital Investment Management LPinvestment adviser, partnership | 1.4M | 10.0% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Capital Holdings LLCother entity | 1.3M | 9.8% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Capital Master Fund LPpartnership | 1.1M | 8.0% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Capital Opportunity Fund II LLCother entity | 250K | 1.9% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Horizon Fund LPpartnership | 25K | 0.2% | 2026-08-21 |
| 2026-08-25 | 13D/Ano. 2 | Velan Horizon GP LLCother entity | 25K | 0.2% | 2026-08-21 |
| 2026-06-18 | 13G | Millennium Management LLCother entity | 521K | 5.4% | 2026-06-11 |
| 2026-06-18 | 13G | Israel A. Englanderindividual | 521K | 5.4% | 2026-06-11 |
| 2026-06-18 | 13G | Millennium Group Management LLCother entity | 521K | 5.4% | 2026-06-11 |
| 2026-06-18 | 13G | Integrated Core Strategies (US) LLCother entity | 521K | 5.4% | 2026-06-11 |
| 2026-05-15 | 13G/Ano. 2 | Wilmot B. Harkeyparent holding company | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Daniel Mackparent holding company | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Nantahala Capital Management, LLCinvestment adviser | 0 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Steven A. Cohenindividual | 2 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Capital Advisors, Inc.corporation | 2 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Asset Management, L.P.partnership | 2 | 0.0% | 2026-03-31 |
| 2026-05-15 | 13G | Sirenia Capital Management LPinvestment adviser, partnership | 600K | 7.2% | 2026-03-31 |
| 2026-05-15 | 13G | Alex Silversteinparent holding company, individual | 600K | 7.2% | 2026-03-31 |
| 2026-05-15 | 13G | David Rosenparent holding company, individual | 688K | 7.7% | 2025-03-31 |
| 2026-05-15 | 13G | Rubric Capital Management LPinvestment adviser, partnership | 688K | 7.7% | 2025-03-31 |
| 2026-03-16 | 13G | Perceptive Advisors LLCinvestment adviser | 563K | 6.7% | 2026-03-09 |
| 2026-03-16 | 13G | Joseph Edelmanindividual | 563K | 6.7% | 2026-03-09 |
| 2026-03-16 | 13G | Perceptive Life Sciences Master Fund, Ltd.corporation | 563K | 6.7% | 2026-03-09 |
13F holders
Tracked managers holding EDSA at their latest 13F. JSON2 of the 30 tracked managers held EDSA at their latest 13F, $4.7M in total at quarter-end prices. Millennium Management is the largest at $4.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 562K | $4.6M | 0.00% | new |
| Two Sigma Investments | 2026-06-30 | 14K | $114K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Edesa Biotech in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Edesa Biotech (EDSA), SEC CIK 1540159, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-26.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-05.JSON and CSV
- Company record
- EDGAR filing index for CIK 1540159Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of EDSA is sold short?
203,556 shares were held short at the 2026-09-30 settlement, 4.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is EDSA's daily short volume?
On 2026-10-23, 6,190 of the 10,871 EDSA shares reported to FINRA were sold short, 56.9% of the day's reported volume. Short volume is a flow for one day, not a position.
Does EDSA have fails to deliver?
The SEC's latest file shows 24 EDSA shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are EDSA insiders buying or selling?
No open-market insider trades were reported for EDSA in the last 90 days. The most recent filings are listed below. Latest filing: Nijhawan Pardeep (Chief Executive Officer) on 2026-10-05.
Who owns 5% or more of EDSA?
23 holders report 5% or more of EDSA in their latest filing, 8 on Schedule 13D (active intent). The largest reported stake is Pardeep Nijhawan at 16.3% of the class (2,613,492 shares), filed 2026-08-25 for an event on 2026-08-21.
Which tracked 13F managers own EDSA?
2 of the 30 tracked 13F managers held EDSA shares at their latest filing, $4.7M in all. The largest: Izzy Englander's Millennium Management (562K shares, $4.6M), Two Sigma Investments (14K shares, $114K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.